期刊文献+

基于DRGs的药品综合管理模式在控制住院患者药品费用中的效果分析 被引量:8

Analysis on the effect of comprehensive drug management model based on DRGs in controlling the drug cost of inpatients
原文传递
导出
摘要 目的基于诊断相关分组(DRGs)建立药品综合管理模式,合理控制住院患者药品费用,为促进临床合理用药水平提供参考依据。方法基于DRGs建立药品综合管理模式,比较管控前后5年的住院患者例均药品费用、药品占比、重点监控的药品金额及占比情况。结果管控后,住院患者例均药品费用由2017年的3496.3元下降到2021年的2609.7元、药品占比由2017年的29.0%下降到2021年的17.4%,辅助用药、中成药占比下降和住院药品占比下降有相关性(P<0.05);全院大部分绩效科室的人均住院药品费用和药品占比下降明显;精细化管理中典型科室骨科DRGs管理成效显著,住院患者例均药品费用由2017年的4339.2元下降到2021年的2577.5元、药品占比由2017年的17.5%下降到2021年的8.7%。结论基于DRGs建立药品综合管理模式,能够合理控制住院患者药品费用,提高临床合理用药水平,促进医保基金的合理使用。 Objective To establish a comprehensive drug management model based on diagnosis related groups(DRGs),so as reasonably control the average drug cost of inpatients and provide reference basis for promoting rational drug use in the clinic.Methods The hospital established and implemented comprehensive drug management measures based on DRGs.Then,we compared the average drug cost,the proportion of drugs and the amount and proportion of several major categories of drugs of inpatients before and after implementation.Results After the imprementation of management measures,the average drug cost per inpatient decreased from 3496.3 yuan in 2017 to 2609.7 yuan in 2021,and the proportion of drugs decreased from 29.0%in 2017 to 17.4%in 2021.The drug proportion’s decline showed a positive correlation with the decline of adjuvant medicine and proprietary Chinese medicines(P<0.05).The drug cost and drug proportion of most performance departments in the hospital decreased significantly.Notably,the DRGs management in department of orthopedics achieved remarkable results,the average drug cost per inpatient decreased from 4339.2 yuan in 2017 to 2577.5 yuan in 2021,and the proportion of drugs decreased from 17.5%yuan in 2017 to 8.7%in 2021.Conclusion The establishment of drug comprehensive management model based on DRGs can reasonably control the drug cost of inpatients,improve clinical rational drug use,and promote the appropriate use of nealth insurance fund.
作者 韩凤昭 李振知 肖怀玉 张思洁 杨文华 HAN Feng-zhao;LI Zhen-zhi;XIAO Huai-yu;ZHANG Si-jie;YANG Wen-hua(Department of Pharmacy,Beijing Huairou Hospital,Beijing 101400,China)
出处 《临床药物治疗杂志》 2022年第8期32-38,共7页 Clinical Medication Journal
关键词 诊断相关分组 综合管理 药品费用 辅助用药 中成药 抗菌药物 DRGs comprehensive management drug cost adjuvant medicine proprietary Chinese medicine antibiotics
作者简介 通讯作者:韩凤昭,硕士,副主任药师,研究方向:药事管理、临床药学。E-mail:597587941@qq.com。
  • 相关文献

参考文献11

二级参考文献114

共引文献175

同被引文献88

引证文献8

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部